Back

The impact of apolipoprotein B levels on left ventricular ejection fraction in heart failure patients

17 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Biomarkers in heart failure and kidney disease Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Ioana-Patricia Rodean

Emergency County Hospital of Targu Mures, Targu Mures (Romania)

4 More presentations in this session

Presentation thumbnail
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
Doctor R. Miftode (Iasi, RO)
Abstract Slides Video
Presentation thumbnail
Albuminuria predicts progression of diastolic dysfunction in patients with cardiovascular risks
Doctor K. Min (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Crucial relationship between right ventricular to pulmonary circulation uncoupling and natriuretic peptides levels in heart failure during maximal exercise
Doctor G. Crisci (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Correlation of NT-proBNP, copeptin, cystatin C, apelin, sMCAM/sCD146 and ADMA concentration with parameters of volum status in patients with chronic heart failure
Professor F. Malek (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in heart failure and kidney disease

The Event

Event poster

Heart Failure 2025

17 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein A and the risk of developing left ventricle systolic dysfunction in the immediate post-acute coronary syndrome period.
thumbnail
Congress Presentation
Prognostic significance of left ventricular ejection fraction in acute coronary syndromes
thumbnail
Congress Presentation
LVEF to characterise heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources